Merkel Cell Carcinoma and Immunosuppression: What We Still Need to Know

Successful Administration of Ipilimumab to Two Kidney Transplantation Patients With Metastatic Melanoma

(2014) Evan J. Lipson et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Statins and the Risk of Death in Patients With Prostate Cancer

(2013) Oriana Yu et al.   JOURNAL OF CLINICAL ONCOLOGY

PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival

(2013) E. J. Lipson et al.   Cancer Immunology Research

Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesis

(2012) D. Viarisio et al.   JOURNAL OF GENERAL VIROLOGY

HPV 5 and 8 E6 Abrogate ATR Activity Resulting in Increased Persistence of UVB Induced DNA Damage

(2012) Nicholas A. Wallace et al.   PLoS Pathogens

A Case-Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients

(2011) C. M. Proby et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Opposing roles for calcineurin and ATF3 in squamous skin cancer

(2010) Xunwei Wu et al.   NATURE

Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma

(2009) V Koljonen et al.   BRITISH JOURNAL OF CANCER

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

(2008) A. Bashey et al.   BLOOD

Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma

(2008) H. Feng et al.   SCIENCE